Applications of Biological Dosimetry Methods in Radiation Oncology, Nuclear Medicine, and Diagnostic and Interventional Radiology (MEDBIODOSE)

Open for proposals

Project Type

Coordinated Research Project

Project Code

E35010

CRP

2109

Approved Date

5 October 2016

Status

3 - Active - Ongoing

Start Date

10 July 2017

Expected End Date

9 July 2023

Participating Countries

Algeria
Argentina
Australia
Brazil
Canada
Chile
China
Cuba
France
India
Indonesia
Israel
Japan
Lithuania
Mexico
Philippines
Russian Federation
Saudi Arabia
Singapore
Slovakia
South Africa
Sudan
Thailand
Ukraine
United Kingdom of Great Britain and Northern Ireland
Uruguay
Viet Nam

Description

New title:Applications of biological dosimetry methods in radiation oncology, nuclear medicine, diagnostic and interventional radiology Acronym: MEDBIODOSE Biological dosimetry is one of the most developed branches of radiobiology; its technical aspects, particularly those relevant to cytogenetic assays, are well refined and have reached the level of the international standardisation. The aim of this CRP is to address various uses of biological dosimetry methods in radiation oncology, nuclear medicine, diagnostic and interventional radiology. It will include filing in gaps in knowledge and developing new approaches to assist with the transition to personalised medicine. The proposed CRP will build upon the success of a previous IAEA project E35008 on ‘Strengthening of “Biological dosimetry” in IAEA Member States: Improvement of current techniques and intensification of collaboration and networking among the different institutes’ (2012-2016)’. This project will bring together a number of institutions from LMI and HI MSs to progress toward the common goal of improving the quality of health care using radiation technologies.

Objectives

To sustain and enhance the scope of biodosimetry services to radiation oncology, nuclear medicine, diagnostic and interventional radiology.

Specific objectives

Collect biodosimetry data on patients exposed to radiation for medical purposes to fill in knowledge gaps and assist with the transition to personalised medicine.

Establish a research biological dosimetry network for clinical applications.

Propose and test biodosimetry methodology for comprehensive assessment of consequences of medical radiation exposures, including accidental overexposure.

Develop biodosimetry based methods for prediction or prognosis of adverse radiotherapy effects and late complications allowing refinement of radiation treatment plans.

To facilitate dialogue between biodosimetry specialists and radiation oncologists.

To transfer biodosimetry methodology into clinical practice in order to improve outcome of radiation medical services in terms of survival, safety and quality of life.

Contact the project officer

Image CAPTCHA

Stay in touch

Newsletter